P/B
0,6
Amarin
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
$249M
Market Cap • 10/23/2026
1989
(37 years)
Founded
1993
(33 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
1,3
P/EBITDA
—
P/OCF
13,7
P/FCF
13,7
P/E
—
BVPS
21
EPS
—
Market Cap
Market Cap
249M
EV
-60,4M
EV/Revenue
-0,3
EV/EBITDA
1,6
EV/EBIT
1,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0,8%
Total Yield
0,8%
Payout
0%
Retained Earnings
-1,7B
Profitability
Gross Margin
42%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
10,2%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
19,3%
% PPE
0,9%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-21,4%
Leverage
N.D./EBITDA
8,1
Debt/Equity
0%
Current Ratio
3,7
Quick Ratio
2,5
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!